Magnitude and Determinant Factors of Pediatrics Seizures in Pediatrics Emergency Unit at Tikur Anbessa Specialized

Asaminew Habtamu1, Rahel Argaw2, Wagari Tuli2

  • 1Institute of Health Science, School of Nursing, Department of Emergency Medicine and Critical Care Nursing, Jimma University, Jimma, Ethiopia.

Behavioural Neurology
|July 24, 2023
PubMed

Insights

Pediatric seizures are a common neurological issue in children, with generalized seizures being most prevalent. Family history and birthplace are significant risk factors for childhood seizures.

Area of Science:

  • Neurology
  • Pediatrics
  • Epidemiology

Background:

  • Epilepsy is a prevalent chronic neurological condition in children globally, with varying severity.
  • Pediatric seizures can result from infections, brain injuries, or anatomical abnormalities.
  • Limited research exists on pediatric seizures in Ethiopia, necessitating local studies.

Purpose of the Study:

  • To investigate the prevalence and associated factors of pediatric seizures.
  • To analyze data from children admitted to Tikur Anbessa pediatric emergency.

Main Methods:

  • A retrospective, institution-based cross-sectional study analyzed 256 patient charts.
  • Data was collected using a checklist and analyzed with descriptive statistics and binary logistic regression.
  • Variables with p<0.25 in bivariate analysis were included in multivariate analysis.

Main Results:

  • The study included 256 patients, with 60.5% being male.
  • Generalized seizures were the most common type observed.
  • Family history and birthplace were significantly correlated with pediatric seizures (AOR=2.68, p=0.02 and AOR=2.8, p=0.04).

Conclusions:

  • Generalized seizures are the most frequent form of pediatric convulsions.
  • Family history and birthplace are identified as key risk factors for pediatric seizures.
  • Healthcare providers should focus on identified risk factors to manage childhood seizures effectively.
Abstract

Related Concept Videos

Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
419
Arteries of the Lower Limbs01:24

Arteries of the Lower Limbs

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
215
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
69
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
346